Phase 1 Pancreatic Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with a solid tumour cancer (confirmed by laboratory testing of tissue) that has a specific gene change called a KRAS mutation, detected through an approved molecular test.
• People whose cancer cannot be removed by surgery, or has spread to other parts of the body.
• People whose cancer has continued to grow after standard treatments, who could not tolerate standard treatments, or who have chosen not to receive standard treatments for their cancer type and stage.
• People who are reasonably active and able to carry out daily activities, as measured by a standard medical scale (confirm with trial site).
• People whose liver, kidneys, and other organs are functioning well enough to meet the trial's requirements (confirm with trial site).

Who may not be able to join:

• People who have previously been treated with a KRAS inhibitor medication, although some exceptions may apply as described in the full trial documents (confirm with trial site).
• People who have a known condition that prevents them from swallowing or properly absorbing a tablet or capsule taken by mouth.
• Other eligibility requirements not listed here may also apply (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.